Studies dating back decades indicate that natural killer cells aren’t up to the job of killing infected cells in ME/CFS. Killing isn’t the only thing these cells do, though, the’re also involved in immune functioning. A large study examining the...
If you think ME/CFS and FM are behind the eight ball at the NIH, then check out postural orthostatic tachycardia syndrome (POTS), a common comorbidity. The NIH doesn’t even measure POTS funding but then how could it? POTS doesn’t even have a designated...
Carmen Scheibenbogen is unusual. Not only has she become one of the most prolific ME/CFS researchers of the past few years but she’s doing her research from a country – Germany – which hardly acknowledges the disease’s existence. Plus,...
Difference-Maker Unlike FMS, SFPN has identifiable pathology, physiology, and causes, and thus is definitionally a disease. Oaklander et. Al. Dr. Anne Oaklander MD, PhD, is making a difference – maybe a very big difference in the lives of many. Making a...
The outcome of a positive Rituximab trial for ME/CFS – possibly, finally, an FDA approved drug, relief for many, acceptance for this disease, increased research funding – would have been spectacular but Dr. Mella reported this week in Norway that the trial...
Please support Health Rising in our Quickie Summer Donation Drive! Our goal is $15,000.Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.